|
Guangzhou Egg Biotechnology Co., Ltd. |
|
|
|
|
(CNPQ) Conselho Nacional de Desenvolvimento Cientifíco e Tecnoloǵico |
|
|
|
|
(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo |
|
|
|
|
Anacor Pharmaceuticals |
|
|
|
|
AstraZeneca |
|
|
|
|
Bill & Melinda Gates Foundation |
|
|
|
|
Boston University |
|
|
|
|
Calibr, The Scripps Research Institute |
|
|
|
|
CDC TBTC |
|
|
|
|
EDCTP |
|
|
|
|
German Center for Infection Research (DZIF) |
|
|
|
|
GlaxoSmithKline |
|
|
|
|
Hans-Knöll Institute, Jena |
|
|
|
|
iM4TB - Innovative Medicines for Tuberculosis |
|
|
|
|
Institute of Materia Medica |
|
|
|
|
Institute of Materia Medica, CAMS & PUMC |
|
|
|
|
IUATLD, Inc. |
|
|
|
|
Janssen Research & Development, LLC |
|
|
|
|
LegoChem |
|
|
|
|
Lilly TB Drug Discovery Initiative |
|
|
|
|
Médecins Sans Frontières |
|
|
|
|
Michigan State University |
|
|
|
|
Microbiotix, Inc. |
|
|
|
|
MicuRx Pharmaceuticals, Inc. |
|
|
|
|
Nearmedic Plus LLC |
|
|
|
|
NIAID, NIH, DHHS |
|
|
|
|
Novartis |
|
|
|
|
Otsuka Pharmaceutical Development & Commercialization, Inc. |
|
|
|
|
PanACEA |
|
|
|
|
Purdue University |
|
|
|
|
Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund |
|
|
|
|
Qurient Co., Ltd |
|
|
|
|
Sanofi |
|
|
|
|
São Paulo State University (UNESP) |
|
|
|
|
Sequella, Inc |
|
|
|
|
Spero Therapeutics, LLC |
|
|
|
|
SPRINT TB (National University of Singapore) |
|
|
|
|
St. George's Hospital University of London |
|
|
|
|
TB Alliance |
|
|
|
|
TB Drug Accelerator |
|
|
|
|
The Aurum Institute NPC |
|
|
|
|
University College, London |
|
|
|
|
University of Auckland |
|
|
|
|
University of Illinois at Chicago |
|
|
|
|
University of Munich |
|
|
|
|
USAID |
|
|
|
|
Weill Medical College of Cornell University |
|
|
|
